News
-
-
PRESS RELEASE
Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research
Onco-Innovations' Inka Health Corp. enters Expression of Interest with Quantify Research for collaboration in advanced data analytics and oncology research to enhance cancer treatment insights -
-
PRESS RELEASE
Onco-Innovations' Nanoparticle Formulation PNKP Technology Combined with Radiation Therapy, and as a Standalone Treatment, Shown in Studies to Slow Colorectal Cancer Tumour Growth
Onco-Innovations Limited announces promising results in slowing colorectal cancer growth using nanoparticle PNKP Compound as standalone and combination treatment, targeting cancer cells precisely -
-
PRESS RELEASE
Onco-Innovations' Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study
Onco-Innovations Limited introduces exclusive PNKP inhibitors to enhance sensitivity of cancer cells to radiation, potentially revolutionizing targeted cancer treatments -
-
PRESS RELEASE
Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research
Onco-Innovations announces Expression of Interest with Quantify Research, a global healthcare data analytics leader, to explore collaborations in advanced data analytics and oncology research -
-
PRESS RELEASE
Onco-Innovations Completes Acquisition of Inka Health to Accelerate AI-Driven Cancer Research and Drug Development
Onco-Innovations Limited completes acquisition of Inka Health Corp, a Canadian-based software company pioneering AI-driven analytics in cancer research and drug development. Strengthens precision oncology capabilities